Net benefit

SS Sarah J. Stock
MH Margaret Horne
MB Merel Bruijn
HW Helen White
KB Kathleen A. Boyd
RH Robert Heggie
LW Lisa Wotherspoon
LA Lorna Aucott
RM Rachel K. Morris
JD Jon Dorling
LJ Lesley Jackson
MC Manju Chandiramani
AD Anna L. David
AK Asma Khalil
AS Andrew Shennan
GB Gert-Jan van Baaren
VH Victoria Hodgetts-Morton
TL Tina Lavender
ES Ewoud Schuit
SH Susan Harper-Clarke
BM Ben W. Mol
RR Richard D. Riley
JN Jane E. Norman
JN John Norrie
request Request a Protocol
ask Ask a question
Favorite

In order to evaluate the potential clinical value of using the risk prediction model to inform decision-making, we performed net benefit analyses (which was not prespecified), where benefits and harms of a risk prediction model are put on the same scale to allow direct comparison [28]. We plotted the standardised net benefit across a range of predicted risks of preterm birth within 7 days (0% to 20%). For the purpose of this analysis, we assumed that the standard of care for this population with signs and symptoms of preterm labour was to “treat” (e.g., admit to an appropriate hospital, give antenatal corticosteroids and magnesium sulphate) and that a percentage predicted risk of preterm birth would be used for “ruling out” treatment.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A